AFIB vs. SINT, NMRD, BJDX, OSAP, MOTS, DYNT, RSLS, AEMD, GMVDF, and IONM
Should you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Sintx Technologies (SINT), Nemaura Medical (NMRD), Bluejay Diagnostics (BJDX), ProSomnus (OSAP), Motus GI (MOTS), Dynatronics (DYNT), ReShape Lifesciences (RSLS), Aethlon Medical (AEMD), G Medical Innovations (GMVDF), and Assure (IONM). These companies are all part of the "surgical & medical instruments" industry.
Acutus Medical (NASDAQ:AFIB) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, community ranking, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.
Sintx Technologies received 24 more outperform votes than Acutus Medical when rated by MarketBeat users. Likewise, 61.02% of users gave Sintx Technologies an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote.
Sintx Technologies has lower revenue, but higher earnings than Acutus Medical.
56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 3.5% of Acutus Medical shares are held by company insiders. Comparatively, 0.8% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Acutus Medical has a net margin of -166.79% compared to Sintx Technologies' net margin of -318.99%. Acutus Medical's return on equity of -54.97% beat Sintx Technologies' return on equity.
Acutus Medical has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500.
In the previous week, Sintx Technologies had 2 more articles in the media than Acutus Medical. MarketBeat recorded 4 mentions for Sintx Technologies and 2 mentions for Acutus Medical. Acutus Medical's average media sentiment score of 0.15 beat Sintx Technologies' score of -0.06 indicating that Acutus Medical is being referred to more favorably in the media.
Summary
Acutus Medical beats Sintx Technologies on 7 of the 13 factors compared between the two stocks.
Get Acutus Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Acutus Medical Competitors List
Related Companies and Tools
